Total Payments
$48,068
2024 Payments
$3,462
Companies
28
Transactions
141
Medicare Patients
4,164
Medicare Billing
$2.1M
Payment Breakdown by Category
Consulting$42,835 (89.1%)
Food & Beverage$4,141 (8.6%)
Other$895.11 (1.9%)
Travel$171.90 (0.4%)
Research$25.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $42,835 | 16 | 89.1% |
| Food and Beverage | $4,141 | 121 | 8.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $839.52 | 1 | 1.7% |
| Travel and Lodging | $171.90 | 1 | 0.4% |
| Entertainment | $55.59 | 1 | 0.1% |
| Unspecified | $25.00 | 1 | 0.1% |
Payments by Type
General
$48,043
140 transactions
Research
$25.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Quidel Corporation | $37,406 | 19 | $0 (2019) |
| Genentech USA, Inc. | $3,168 | 16 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $3,160 | 2 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $1,211 | 41 | $0 (2024) |
| Notal Vision, Inc. | $839.52 | 1 | $0 (2022) |
| Allergan, Inc. | $801.14 | 16 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $365.28 | 5 | $0 (2019) |
| ABBVIE INC. | $173.46 | 8 | $0 (2024) |
| Carl Zeiss Meditec, Inc. | $137.19 | 1 | $0 (2017) |
| Heidelberg Engineering, Inc. | $85.61 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,462 | 26 | Genentech USA, Inc. ($2,987) |
| 2023 | $3,591 | 22 | Regeneron Pharmaceuticals, Inc. ($3,055) |
| 2022 | $1,576 | 24 | Notal Vision, Inc. ($839.52) |
| 2021 | $427.01 | 18 | Regeneron Healthcare Solutions, Inc. ($193.60) |
| 2020 | $41.16 | 2 | Allergan, Inc. ($27.56) |
| 2019 | $32,513 | 34 | Quidel Corporation ($31,554) |
| 2018 | $6,124 | 8 | Quidel Corporation ($5,852) |
| 2017 | $332.90 | 7 | Carl Zeiss Meditec, Inc. ($137.19) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO, ZYLET | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: EYE CARE | ||||||
| 12/09/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: SOLUTION/ DROPS | ||||||
| 12/08/2024 | Harrow Eye, LLC | IHEEZO (Drug), TRIESENCE | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: OPTOMETRY | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $34.08 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/15/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $33.80 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/08/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/04/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $32.86 | General |
| Category: Ophthalmology | ||||||
| 10/02/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 08/24/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Consulting Fee | Cash or cash equivalent | $2,730.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/23/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/23/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/23/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $33.30 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $37.78 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/05/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $33.28 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/24/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $32.09 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/04/2024 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $149.78 | General |
| 04/24/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 04/10/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: OPTOMETRY | ||||||
| 04/03/2024 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/06/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/20/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: IMMUNOLOGY | ||||||
| 02/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $36.80 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/13/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Immunology and Ophthalmology | ||||||
| 01/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $28.24 | General |
| Category: OPHTHALMOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A SAFETY AND EFFICACY STUDY OF ABICIPAR PEGOL IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION | Allergan Inc. | $25.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,045 | 7,727 | $2.6M | $726,084 |
| 2022 | 11 | 949 | 3,189 | $2.4M | $643,923 |
| 2021 | 13 | 1,092 | 3,434 | $2.3M | $595,538 |
| 2020 | 11 | 1,078 | 2,005 | $881,020 | $160,700 |
Total Patients
4,164
Total Services
16,355
Medicare Billing
$2.1M
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 78 | 660 | $1.5M | $455,940 | 31.1% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 22 | 4,446 | $369,480 | $127,136 | 34.4% |
| 67028 | Injection of drug into eye | Office | 2023 | 166 | 600 | $512,850 | $51,813 | 10.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 272 | 654 | $70,185 | $39,039 | 55.6% |
| 92134 | Imaging of retina | Office | 2023 | 289 | 938 | $80,540 | $26,180 | 32.5% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 56 | 162 | $81,000 | $10,544 | 13.0% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 35 | 132 | $13,000 | $6,721 | 51.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 40 | 40 | $5,849 | $3,333 | 57.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $2,850 | $1,727 | 60.6% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 16 | 17 | $6,200 | $1,583 | 25.5% |
| 92250 | Photography of the retina | Office | 2023 | 34 | 36 | $5,680 | $908.82 | 16.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 15 | $975.00 | $642.75 | 65.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 11 | 12 | $1,640 | $516.78 | 31.5% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 69 | 666 | $1.5M | $477,388 | 31.4% |
| 67028 | Injection of drug into eye | Office | 2022 | 159 | 602 | $564,600 | $51,905 | 9.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 257 | 594 | $63,825 | $35,208 | 55.2% |
| J3590 | Unclassified biologics | Office | 2022 | 14 | 29 | $85,200 | $31,943 | 37.5% |
| 92134 | Imaging of retina | Office | 2022 | 263 | 916 | $78,460 | $25,711 | 32.8% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 59 | 148 | $48,500 | $9,142 | 18.9% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 50 | 154 | $14,800 | $7,544 | 51.0% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 31 | 31 | $4,558 | $2,668 | 58.5% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 13 | 14 | $4,700 | $1,248 | 26.5% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 14 | 15 | $1,940 | $704.78 | 36.3% |
| 92250 | Photography of the retina | Office | 2022 | 20 | 20 | $3,360 | $460.65 | 13.7% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 58 | 580 | $1.4M | $426,133 | 30.5% |
About Dr. Leanne Labriola, DO
Dr. Leanne Labriola, DO is a Ophthalmology healthcare provider based in Urbana, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1063603793.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leanne Labriola, DO has received a total of $48,068 in payments from pharmaceutical and medical device companies, with $3,462 received in 2024. These payments were reported across 141 transactions from 28 companies. The most common payment nature is "Consulting Fee" ($42,835).
As a Medicare-enrolled provider, Labriola has provided services to 4,164 Medicare beneficiaries, totaling 16,355 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology
- Location Urbana, IL
- Active Since 08/07/2007
- Last Updated 12/09/2013
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1063603793
Products in Payments
- EYLEA (Biological) $3,992
- Vabysmo (Drug) $2,959
- OZURDEX (Drug) $493.10
- EYLEA HD (Biological) $378.71
- Eye Health (Device) $183.68
- BEOVU (Drug) $138.80
- CIRRUS HD-OCT (Device) $137.19
- BUPARLISIB (Drug) $121.75
- Spectralis (Device) $85.61
- VABYSMO (Drug) $83.33
- Kahook Dual Blade (Device) $73.57
- California (Device) $55.59
- VYZULTA (Drug) $50.43
- Lucentis (Biological) $50.03
- rocklatan (Drug) $42.72
- VEVYE (Drug) $38.38
- Izervay (Drug) $32.86
- PURIFIED CORTROPHIN GEL (Drug) $32.64
- Humira (Biological) $31.71
- Iluvien (Drug) $29.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Urbana
Aashish Gandhi, Md, MD
Ophthalmology — Payments: $11,384
Ophthalmology $11,384
Fatima Ahmed, Md, MD
Ophthalmology — Payments: $3,145
Ophthalmology $3,145
Tanu Thomas, Md, MD
Ophthalmology — Payments: $1,699
Ophthalmology $1,699
Abu-Bakar Zafar, M.d, M.D
Ophthalmology — Payments: $1,250
Ophthalmology $1,250
Douglas Gray, Md, MD
Ophthalmology
Ophthalmology